Previous 10 | Next 10 |
2023-09-17 07:33:42 ET Summary A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. Introduction The D...
2023-09-17 07:31:40 ET Summary ResMed stock's high valuation from 4 years ago is finally being reflected in the current stock price. The historical earnings pattern of ResMed has been stable and consistent, making it a rare achievement. Using a 10-year earnings CAGR estimate, ...
2023-09-13 08:27:42 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips With the market rallying hard lately, it’s easy to think every stock is participating in the gains. But look a little closer, and you’ll see the rally has been very narrow. Most o...
2023-09-12 15:27:28 ET Summary ResMed is the global leader in the sleep apnea market. Sales growth accelerated during COVID and again recently as a result of a product recall from its major competitor. Despite a strong last quarter the market has marked the stock down due to c...
2023-09-12 11:52:41 ET Summary RMD is a buy as I expect that the market will re-evaluate the stock and return it to its historical average. Sales for ResMed in 4Q23 increased by 23% YoY, driven by device sales and unexpected growth in mask sales. Gross margin pressures persist...
2023-09-12 08:00:00 ET Summary DexCom is a leading healthcare stock that has seen significant growth, with shares returning close to 1,400% in the past decade. DXCM stock has faced resistance and is currently 37% below its all-time high, partly due to competition from weight loss ...
2023-09-09 08:15:00 ET Summary Morningstar's moat indexes have a history of outperforming the S&P 500 over long holding periods. The Moat Index underperformed the S&P 500 by 2% in August, but remains ahead by 500 basis points for the year. Smaller-cap companies had mor...
SAN DIEGO, Sept. 05, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced its participation in two upcoming conferences. Mick Farrell, chief executive officer and chair of the board, and Brett Sandercock, chief financial officer, will participate in a fireside chat at the M...
2023-09-01 06:21:00 ET Every quarter, investors get excited for companies to report earnings. Some want the updated numbers that management teams share. Others are more curious to hear about plans and projections. Executives' comments are well-scripted and aren't usually controversial enoug...
2023-08-30 10:11:37 ET More on Insulet Insulet: Losing More Weight Insulet: High Growth Not Translating To Economic Value For Shareholders (Rating Downgrade) Insulet Corporation ( PODD ) Q2 2023 Earnings Call Transcript Insulet Corporation: Margins Are On...
News, Short Squeeze, Breakout and More Instantly...
2024-06-29 05:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
SAN DIEGO, June 10, 2024 (GLOBE NEWSWIRE) -- In collaboration with leading medical researchers from around the world, ResMed (NYSE: RMD, ASX: RMD) presented 13 new clinical studies at SLEEP 2024, the annual joint meeting of the American Academy of Sleep Medicine and the Sleep Research Society. He...
Among 26 ResMed-supported abstracts, these were the highlights: New findings show positive airway pressure (PAP) therapy reduced risks of death and hospitalization for patients with obstructive sleep apnea (OSA) Prevalence of OSA in the United States expected to increase 26.7%...